Soleno Therapeutics, Inc. Common Stock
XNAS:SLNO
43.7
$42.96 - 4.00
$39.00 - 4.00
$41.34
$43.7
$41.96
$41.95
90.32
39.43
1169594
1989724.1
49483184.13
Chart
TendieTensor AI Analysis
Company
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
Fundamentals
133
-23.060000
4.610570
100
BBG0024L5B86
BBG0024L5B95
53.15M
53.71M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News